• COVID-19 rapid test has successful lab r

    From ScienceDaily@1337:3/111 to All on Wed Oct 14 21:30:40 2020
    COVID-19 rapid test has successful lab results, research moves to next
    stages
    Engineers and virologists team up for novel approach

    Date:
    October 14, 2020
    Source:
    University of Nevada, Reno
    Summary:
    Rapid detection of the SARS-CoV-2 virus, in about 30 seconds
    following the test, has had successful preliminary results. The
    test uses a nanotube-based electrochemical biosensor, a similar
    technology used for detecting tuberculosis and colorectal cancer
    as well as detection of biomarkers for food safety.



    FULL STORY ========================================================================== Rapid detection of the SARS-CoV-2 virus, in about 30 seconds following
    the test, has had successful preliminary results in Mano Misra's lab
    at the University of Nevada, Reno. The test uses a nanotube-based electrochemical biosensor, a similar technology that Misra has used in
    the past for detecting tuberculosis and colorectal cancer as well as
    detection of biomarkers for food safety.


    ========================================================================== Professor Misra, in the University's College of Engineering Chemical and Materials Department, has been working on nano-sensors for 10 years. He
    has expertise in detecting a specific biomarker in tuberculosis patients' breath using a metal functionalized nano sensor.

    "I thought that similar technology can be used to detect the SARS-CoV-2
    virus, which is a folded protein," Misra said. "This is Point of
    Care testing to assess the exposure to COVID-19. We do not need a
    laboratory setting or trained health care workers to administer the
    test. Electrochemical biosensors are advantageous for sensing purposes
    as they are sensitive, accurate and simple." The test does not require
    a blood sample, it is run using a nasal swab or even exhaled breath,
    which has biomarkers of COVID-19. Misra and his team have successfully demonstrated a simple, inexpensive, rapid and non-invasive diagnostic
    platform that has the potential to effectively detect the SARS-CoV-
    2 virus.

    The team includes Associate Professor Subhash Verma, virologist, and
    Research Scientist Timsy Uppal at the University's School of Medicine,
    and Misra's post- doctoral researcher Bhaskar Vadlamani.

    "Our role on this project is to provide viral material to be used for
    detection by the nanomaterial sensor developed by Mano," Verma said. "Mano contacted me back in April or May and asked whether we can collaborate
    to develop a test to detect SARS-CoV-2 infection by analyzing patients'
    breath. That's where we came in, to provide biological material and
    started with providing the surface protein of the virus, which can be
    used for detecting the presence of the virus." Verma, an expert on
    SARS-CoV-2, synthesized and prepared the antigenic protein of COVID-19
    virus in his laboratory, SARS-CoV-2 receptor binding domain protein,
    for the preliminary testing and determining the sensitivity of our nano
    sensor. Synthesizing and purification of viral proteins is usual and
    routine work in a virology laboratory.

    "Our lab is a virology laboratory, which works on different viruses, and
    we have been working on SARS-CoV-2 from the beginning of the outbreak,"
    he said.

    "Our genomics and diagnostic group have been sequencing the SARS-CoV-2
    from the nasal swabs of COVID-19 patients of the state of Nevada to
    determine mutational changes in the virus while SARS-CoV-2 circulates in
    our population." The team developed co-metal functionalized nanotubes
    as a sensing material for electrochemical detection of the protein. They confirmed the biosensor's potential for clinical application by directly analyzing the RBD of the Spike glycoprotein on the sensor.

    The team plans to move to the next step of sensor validation on the actual COVID-19 patients swabs stored in the Viral Transport Medium and have
    applied for funding to develop a specific and inexpensive point-of-care
    sensor for a rapid detection of COVID-19 virus in saliva or breath of
    infected individuals.

    The developed approach also has the potential for diagnosis of other respiratory viral diseases by identifying appropriate metallic elements
    to functionalize nanotubes.

    The team's article "Functionalized TiO2 nanotube-based Electrochemical Biosensor for Rapid Detection of SARS-CoV-2" has been accepted for
    publication in the biosensors section of the MDPI publication 'Sensors'
    and is available as a preprint at MedRxiv.


    ========================================================================== Story Source: Materials provided by University_of_Nevada,_Reno. Original written by Mike Wolterbeek. Note: Content may be edited for style
    and length.


    ========================================================================== Journal Reference:
    1. Bhaskar Sravan Vadlamani, Timsy Uppal, Subhash C Verma, Manoranjan
    Misra.

    Functionalized TiO2 nanotube-based Electrochemical Biosensor for
    Rapid Detection of SARS-CoV-2. medRxiv, Posted Sept. 11, 2020;
    DOI: 10.1101/ 2020.09.07.20190173 ==========================================================================

    Link to news story: https://www.sciencedaily.com/releases/2020/10/201014141032.htm

    --- up 7 weeks, 2 days, 6 hours, 50 minutes
    * Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1337:3/111)